2 results
Approved WMOCompleted
Primary objective: To demonstrate that QVA149 (110/50 *g o.d.) is at least non-inferior to salmeterol/fluticasone (50/500 *g b.i.d.) in terms of rate of COPD exacerbations.Secondary objectives: Superiority in terms of exacerbation rate. Time to…
Approved WMOCompleted
Study part 1A) To determine specificity and sensitivity of diagnosis of anterior ocular pathology with the smartphone enabled device, as compared to in-clinic slit-lamp and tonometry examination (gold standard).B) To determine ease of use of the…